+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

From
From
Global Glioma Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Glioma Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
From
Brain Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 42 Pages
  • Global
From
From
Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 1175 Pages
  • Global
From
Gliosarcoma - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Gliosarcoma - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • August 2021
  • 263 Pages
  • Global
From
From
Gliosarcoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Gliosarcoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 423 Pages
  • Global
From
Anaplastic Astrocytoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Anaplastic Astrocytoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 251 Pages
  • Global
From
Neuroblastoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1084 Pages
  • Global
From
Oligodendroglioma - Pipeline Review, H2 2020 - Product Thumbnail Image

Oligodendroglioma - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 175 Pages
  • Global
From
Recurrent Malignant Glioma - Pipeline Review, H1 2020 - Product Thumbnail Image

Recurrent Malignant Glioma - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 55 Pages
  • Global
From
From
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2020 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2766 Pages
  • Global
From
Melanocyte Protein PMEL - Pipeline Review, H2 2019 - Product Thumbnail Image

Melanocyte Protein PMEL - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 53 Pages
  • Global
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more